Korea Kolmar to supply generic CNS treatment to Abbott

[THE INVESTOR] Korea Kolmar has signed an agreement with Abbott Korea for the exclusive supply of drugs, it announced on July 27. It will be a contract manufacturing organization for two treatments for central nerve system disorder, including Aerica capsule that contains the active substance pregabalin. Kolmar Korea’s own lab developed the pharmaceutical preparation and it has been approved to manufacture the drug.The domestic market for pregabalin, known to be effective for reducing central neu

July 27, 2016

Samsung BioLogics to make IPO debut in November

[THE INVESTOR] Samsung BioLogics, the biosimilar drug producer of Samsung Group, is expected to make its long-awaited stock debut on Korea’s main bourse KOSPI in November. According to industry sources on July 27, the company will submit its IPO application on Aug. 2 that will be reviewed by the Korea Exchange for 45 days. Samsung BioLogics plantBioLogics’ stock debut will become this year’s largest IPO in Korea after the much-hyped 5 trillion won (US$4.40 billion) IPO of Hotel Lotte was delayed

July 27, 2016

BITComputer to provide telemedicine system to Mongolia

[THE INVESTOR] BIT Computer has received a 2 billion won (US$1.76 million) order to supply telemedicine system from the Mongolian government, it announced on July 19. The government is building a new National Diagnostic and Treatment Center in its capital Ulaanbataar and aims to provide remote medical treatment in cooperation with 12 medical facilities nearby. The company already has won the contract for information system for the state hospital. BIT Computer is a leader in medical information m

July 19, 2016